BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 9118104)

  • 1. Antagonism of endotoxin-induced disruption of equine bowel motility by flunixin and phenylbutazone.
    King JN; Gerring EL
    Equine Vet J Suppl; 1989 Jun; (7):38-42. PubMed ID: 9118104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The action of low dose endotoxin on equine bowel motility.
    King JN; Gerring EL
    Equine Vet J; 1991 Jan; 23(1):11-7. PubMed ID: 2015801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of flunixin meglumine and meloxicam for post operative management of horses with strangulating small intestinal lesions.
    Naylor RJ; Taylor AH; Knowles EJ; Wilford S; Linnenkohl W; Mair TS; Johns IC
    Equine Vet J; 2014 Jul; 46(4):427-34. PubMed ID: 24372991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of detomidine, butorphanol, flunixin meglumine and xylazine in clinical cases of equine colic.
    Jochle W; Moore JN; Brown J; Baker GJ; Lowe JE; Fubini S; Reeves MJ; Watkins JP; White NA
    Equine Vet J Suppl; 1989 Jun; (7):111-6. PubMed ID: 9118091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicentre, blinded, randomised clinical trial comparing the use of flunixin meglumine with firocoxib in horses with small intestinal strangulating obstruction.
    Ziegler AL; Freeman CK; Fogle CA; Burke MJ; Davis JL; Cook VL; Southwood LL; Blikslager AT
    Equine Vet J; 2019 May; 51(3):329-335. PubMed ID: 30156312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antagonism of endotoxin-induced disruption of equine gastrointestinal motility with the platelet-activating factor antagonist WEB 2086.
    King JN; Gerring EL
    J Vet Pharmacol Ther; 1990 Dec; 13(4):333-9. PubMed ID: 2287025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cisapride in the prophylaxis of equine post operative ileus.
    Gerring EL; King JN
    Equine Vet J Suppl; 1989 Jun; (7):52-5. PubMed ID: 9118107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the ability of carprofen and flunixin meglumine to inhibit activation of nuclear factor kappa B.
    Bryant CE; Farnfield BA; Janicke HJ
    Am J Vet Res; 2003 Feb; 64(2):211-5. PubMed ID: 12602591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of single-dose intravenous phenylbutazone and flunixin meglumine before, during and after exercise in an experimental reversible model of foot lameness in horses.
    Foreman JH; Grubb TL; Inoue OJ; Banner SE; Ball KT
    Equine Vet J Suppl; 2010 Nov; (38):601-5. PubMed ID: 21059067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental uses of flunixin meglumine and phenylbutazone in food-producing animals.
    Kopcha M; Ahl AS
    J Am Vet Med Assoc; 1989 Jan; 194(1):45-9. PubMed ID: 2644181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of phenylbutazone alone or in combination with flunixin meglumine on blood protein concentrations in horses.
    Reed SK; Messer NT; Tessman RK; Keegan KG
    Am J Vet Res; 2006 Mar; 67(3):398-402. PubMed ID: 16506899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of force plate analysis to compare the analgesic effects of intravenous administration of phenylbutazone and flunixin meglumine in horses with navicular syndrome.
    Erkert RS; MacAllister CG; Payton ME; Clarke CR
    Am J Vet Res; 2005 Feb; 66(2):284-8. PubMed ID: 15757129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COX-1 and COX-2 inhibition in horse blood by phenylbutazone, flunixin, carprofen and meloxicam: an in vitro analysis.
    Beretta C; Garavaglia G; Cavalli M
    Pharmacol Res; 2005 Oct; 52(4):302-6. PubMed ID: 15939622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of slow infusion of a low dosage of endotoxin in healthy horses.
    Clark ES; Moore JN
    Equine Vet J Suppl; 1989 Jun; (7):33-7. PubMed ID: 9118103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postoperative analgesia using phenylbutazone, flunixin or carprofen in horses.
    Johnson CB; Taylor PM; Young SS; Brearley JC
    Vet Rec; 1993 Oct; 133(14):336-8. PubMed ID: 8236675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative effects of phenylbutazone, naproxen and flunixin meglumine on equine platelet aggregation and platelet factor 3 availability in vitro.
    Johnstone IB
    Can J Comp Med; 1983 Apr; 47(2):172-9. PubMed ID: 6883184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum thromboxane in the horse and its inhibition by aspirin, phenylbutazone and flunixin.
    Lees P; Ewins CP; Taylor JB; Sedgwick AD
    Br Vet J; 1987; 143(5):462-76. PubMed ID: 3119142
    [No Abstract]   [Full Text] [Related]  

  • 18. Modulation of arachidonic acid metabolism in endotoxic horses: comparison of flunixin meglumine, phenylbutazone, and a selective thromboxane synthetase inhibitor.
    Moore JN; Hardee MM; Hardee GE
    Am J Vet Res; 1986 Jan; 47(1):110-3. PubMed ID: 3080926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the effects of ketoprofen and flunixin meglumine on the in vitro response of equine peripheral blood monocytes to bacterial endotoxin.
    Jackman BR; Moore JN; Barton MH; Morris DD
    Can J Vet Res; 1994 Apr; 58(2):138-43. PubMed ID: 8004539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro effects of cyclooxygenase inhibitors in whole blood of horses, dogs, and cats.
    Brideau C; Van Staden C; Chan CC
    Am J Vet Res; 2001 Nov; 62(11):1755-60. PubMed ID: 11703020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.